Formulation and evaluation of insulin dry powder for inhalation

Drug Development and Industrial Pharmacy

Volumn 32, Issue 6, 2006, Pages 677-686

  Mahesh Kumar, T ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Carrier; Deposition; Impinger; Lactose; Lyophilization; Particle size

Indexed keywords

DRUG CARRIER; INSULIN; LACTOSE; RESPITOSE;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SCREENING; DRY POWDER; GLUCOSE BLOOD LEVEL; GUINEA PIG; IN VIVO STUDY; INHALATION; INHALER; MOISTURE; NONHUMAN; PARTICLE SIZE; RESPIRATORY SYSTEM;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; GUINEA PIGS; HYPOGLYCEMIC AGENTS; INSULIN; LACTOSE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS;

EID: 33746792727     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600712862     Document Type: Article

References (20)

1. Carr, R. L. (1965) Evaluating flow properties of solids. Chem. Engg., 72, 163-168.
2. Ganderton, D., & Kassem, N. M. (1992) Dry powder inhalers. In Advances in Pharmaceutical Sciences, Ganderton, D., Jones, T., Eds. London: Academic Press, 6, 165-191.
3. Gibaldi, M., & Perri, D. (1982) Pharmacokinetics (2nd ed.) New York: Marcel Dekker.
4. Hickey, A. J., Concession, N. M., Van Oort, N. M., & Platz, R. M. (1994) Factors influencing the dispersion of dry powders as aerosols. Pharm. Tech., 8, 58-82.
5. Hickey, J. H., Gonda, I., Irwin, W. J., & Fildes, F. J. T. (1990) Factors influencing the dispersion of dry powders as aerosols. J. Pharm. Sci., 79, 1009-1014.
6. Hindle, M., & Byron, P. R. (1995) Dose emissions from marketed inhalers. Int. J. Pharm., 116, 169-177.
7. Hinds, W. C. (1982) Adhesion of particles. In Aerosol Technology: Properties, Behaviour and Airborne Particles; Hinds, W. C., Ed. New York: Wiley, 127-132.
8. Hyvärinen, A., & Nike, E. A. (1962) Specific determination of blood glucose with O-toluidine. Clin Chim Acta., 7, 142-143.
9. Joshi, M. R., & Misra, A. N. (2003) Dry powder inhalation of liposomal ketotifen fumarate: Formulation and characterization. Int. J. Pharm., 223, 15-27.
10. Mahesh Kumar, T., & Misra A. N. (2003) Influence of absorption promoters on pulmonary insulin bioactivity. AAPS Pharm. Sci. Tech., 4 (2), 127-138.
11. Niven, R. W. (1995) Delivery of biotherapeutics by inhalation aerosol. Crit. Rev. Ther. Drug Carrier Syst., 12, 151-231.
12. Patton, J. S., Trinchero, P., & Platz, R. M. (1994) Bioavailability of pulmonary delivered peptide and protein: interferon alpha, calcitonin and parathyroid hormones. J. Cont. Rel., 28, 79-85.
13. Pitcairn, G., Langhetti, G., Ventura, P., & Newman, S. W. (1994) A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler at two inhaled flow rates. Int. J. Pharm., 102, 11-18.
14. Prime, D., Atkins, P. J., Slater, A., & Sumby, B. (1997) Review of dry powder inhalers. Adv. Drug Del. Rev. 51-58.
15. Smith, P. L. (1997) Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery. J. Control. Rel., 46, 99-106.
16. Srichana, T. (1998) Protein deposition from dry powder inhalers: fine particle multiplet's as performance modifiers. Pharm. Res., 15(4), 562-569.
17. Srichana, T., Martin, G. P., & Marriott, C. (1986) The effect of device design on drug deposition from dry powder inhaler formulations determined in vitro at different flow rates. Proc. Drug Deliv. Lungs. Aerosol Soc. Bristol., 7, 36-39.
18. Staniforth, J. N., Rees, J. E., Lai, F. K., & Hersey, J. A. (1982) Interparticle forces in binary and ternary ordered powder mixes. J. Pharm. Pharmacol., 34, 141-145.
19. Stanley, S. D. (1999) Delivery of peptide and non-peptide drugs through the respiratory tract. Pharm. Sci. Tech. Today. 12, 450-459.
20. Wall, D. A. (1995) Pulmonary absorption of peptides and proteins. Drug Del., 2, 1-20.